CELLMED 2023 KCI Impact Factor : 0.02
-
pISSN : 3022-6805 / eISSN : 3022-6791
- https://journal.kci.go.kr/cellmed
pISSN : 3022-6805 / eISSN : 3022-6791
AIMS AND SCOPE
Cellmed Orthocellular Medicine Pharmaceutical Association (COMPA) aims for the development of medicine combined with Humanities through human agony, rich experience and wisdom about medicine based on spirit of humanity. COMPA plays an active role in promoting the exchange of academic achievements of worldwide scholars who are interested in this field for the purpose of developing humanitas medicine by submitting their achievements through our international journal, a CELLMED.
The CELLMED journal publishes findings of significance in all areas of medicine including medical classics, medical history, clinical medicine, herbology, prescriptionology, pharmacology, physiology, pathology, preventive medicine, nutrition, acupuncture, moxibustion, and interdisciplinary areas. The journal also welcomes studies that involve models relevant to medical theory and describing molecular mechanisms. Manuscripts from any other related fields of studies that can significantly contribute to the development of humanitas medicine are welcomed as review articles.
---------------------------------------------------------------------------------------------------
Notice
Original article should include the findings of significance in all areas of medicine
----------------------------------------------------------------------------------------------------
CELLMED journal is published quarterly on the last days of February, May, August, and November by Cellmed Orthocellular Medicine and Pharmaceutical Association (COMPA).
CELLMED journal is an online-only, peer-reviewed, open access journal.
compa-editorialteam@compa.co.kr